<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>finanziamenti - Le Fonti New Pharma Italy</title>
	<atom:link href="https://www.newpharmaitaly.it/tag/finanziamenti/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/tag/finanziamenti/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Fri, 19 Jun 2020 12:18:36 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://www.newpharmaitaly.it/wp-content/uploads/2022/12/cropped-favicon-new-pharma-italy-32x32.jpg</url>
	<title>finanziamenti - Le Fonti New Pharma Italy</title>
	<link>https://www.newpharmaitaly.it/tag/finanziamenti/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Huawei Launches FusionServer Pro V6 Intelligent Server Based on the 3rd Gen Intel Xeon Scalable Processor </title>
		<link>https://www.newpharmaitaly.it/huawei-launches-fusionserver-pro-v6-intelligent-server-based-on-the-3rd-gen-intel-xeon-scalable-processor/</link>
					<comments>https://www.newpharmaitaly.it/huawei-launches-fusionserver-pro-v6-intelligent-server-based-on-the-3rd-gen-intel-xeon-scalable-processor/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Fri, 19 Jun 2020 12:18:36 +0000</pubDate>
				<category><![CDATA[Immedia press]]></category>
		<category><![CDATA[Banche]]></category>
		<category><![CDATA[covid19]]></category>
		<category><![CDATA[decreto liquidità]]></category>
		<category><![CDATA[finanziamenti]]></category>
		<category><![CDATA[garanzie]]></category>
		<category><![CDATA[imprese]]></category>
		<category><![CDATA[pmi]]></category>
		<category><![CDATA[sace]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/immediapress/ict/2020/06/19/huawei-launches-fusionserver-pro-intelligent-server-based-the-gen-intel-xeon-scalable-processor_yZZj2UtbDUbZXw11hQ2qsN.html</guid>

					<description><![CDATA[<p>SHENZHEN, China, June 19, 2020 /PRNewswire/ -- Today, the Huawei Computing Product Line officially released the latest member to their family – the next-generation FusionServer Pro V6 intelligent server. This product is a state-of-the-art technology running on the 3rd Gen Intel...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/huawei-launches-fusionserver-pro-v6-intelligent-server-based-on-the-3rd-gen-intel-xeon-scalable-processor/">Huawei Launches FusionServer Pro V6 Intelligent Server Based on the 3rd Gen Intel Xeon Scalable Processor </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/huawei-launches-fusionserver-pro-v6-intelligent-server-based-on-the-3rd-gen-intel-xeon-scalable-processor/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Spread Trading, la nuova frontiera del Trading Online per ottenere risultati investendo sulle materie prime. </title>
		<link>https://www.newpharmaitaly.it/spread-trading-la-nuova-frontiera-del-trading-online-per-ottenere-risultati-investendo-sulle-materie-prime/</link>
					<comments>https://www.newpharmaitaly.it/spread-trading-la-nuova-frontiera-del-trading-online-per-ottenere-risultati-investendo-sulle-materie-prime/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Thu, 18 Jun 2020 22:58:17 +0000</pubDate>
				<category><![CDATA[Immedia press]]></category>
		<category><![CDATA[Banche]]></category>
		<category><![CDATA[credito]]></category>
		<category><![CDATA[debito]]></category>
		<category><![CDATA[decreto liquidità]]></category>
		<category><![CDATA[finanziamenti]]></category>
		<category><![CDATA[imprese]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/immediapress/economia-e-finanza/2020/06/19/spread-trading-nuova-frontiera-del-trading-online-per-ottenere-risultati-investendo-sulle-materie-prime_ABjF91anMKpPS6KeL9UIvK.html</guid>

					<description><![CDATA[<p> Milano, 19 Giugno 2020 - Durante il lockdown, una delle attività in maggior incremento è stato il trading online, ovvero la possibilità di investire anche piccole cifre di denaro direttamente dal proprio smartphone o dal computer, con una prospettiva di...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/spread-trading-la-nuova-frontiera-del-trading-online-per-ottenere-risultati-investendo-sulle-materie-prime/">Spread Trading, la nuova frontiera del Trading Online per ottenere risultati investendo sulle materie prime. </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/spread-trading-la-nuova-frontiera-del-trading-online-per-ottenere-risultati-investendo-sulle-materie-prime/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Malattie reumatiche, al via campagna social &#8216;Obiettivo remissione&#8217; </title>
		<link>https://www.newpharmaitaly.it/malattie-reumatiche-al-via-campagna-social-obiettivo-remissione/</link>
					<comments>https://www.newpharmaitaly.it/malattie-reumatiche-al-via-campagna-social-obiettivo-remissione/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Tue, 16 Jun 2020 09:38:23 +0000</pubDate>
				<category><![CDATA[Attualità]]></category>
		<category><![CDATA[abi]]></category>
		<category><![CDATA[Banche]]></category>
		<category><![CDATA[covid19]]></category>
		<category><![CDATA[crediti]]></category>
		<category><![CDATA[curaitalia]]></category>
		<category><![CDATA[finanziamenti]]></category>
		<category><![CDATA[imprese]]></category>
		<category><![CDATA[moratoria]]></category>
		<category><![CDATA[pmi]]></category>
		<category><![CDATA[prestiti]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/fatti/cronaca/2020/06/16/medicina-malattie-reumatiche-via-campagna-social-obiettivo-remissione_aKxTK6tf3NAPPq9WqtcpdK.html</guid>

					<description><![CDATA[<p>Farmaci biologici, tradizionali e small molecules sempre più in prima linea per la cura delle malattie reumatiche, in particolare dell'artrite reumatoide: di grande efficacia, tollerabili, facili da somministrare e dal profilo di sicurezza sempre più noto, come emerso durante l'ultimo Congresso...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/malattie-reumatiche-al-via-campagna-social-obiettivo-remissione/">Malattie reumatiche, al via campagna social &#8216;Obiettivo remissione&#8217; </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/malattie-reumatiche-al-via-campagna-social-obiettivo-remissione/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
